pharma · Asthma · Pharmacokinetics · AMPH
Amphastar France Pharmaceuticals
Amphastar France Pharmaceuticals patent portfolio — 15 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- USINE SAINT CHARLES, ERAGNY SUR EPTE, 60590, FR, Rancho Cucamonga
- Founded
- 1996
- Employees
- 46
- Programs
- 18
- Drugs
- 15
- Patents
- 15
Amphastar France Pharmaceuticals patents
15 pharmaceutical patents indexed for Amphastar France Pharmaceuticals. 0 expire within 24 months.
Amphastar France Pharmaceuticals has 15 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12383516
Albuterol aerosol suspension formulation for oral inhalation with high amount of green propellant hydrofluoroolefin (HFO) and free of co-solvent
granted -
US 12370241
Nasal powder formulation for treatment of hypoglycemia
granted -
US 12325732
Pro-insulin aspart structure and method for preparing insulin aspart
granted -
US 12226456
Nasal powder formulation for treatment of hypoglycemia
granted -
US 11938089
Medication delivery systems and methods
granted -
US 11524987
Highly purified recombinant human insulin (RHI) API and methods of producing the same
granted -
US 11446360
High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
granted -
US 10851146
Method for preparing liraglutide intermediate polypeptide
granted -
US 10406210
High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
granted -
US 10322168
High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
granted -
US 10258573
Micronized insulin and micronized insulin analogues prepared under acidic conditions, and methods of manufacturing the same under acidic conditions
granted -
US 8974801
Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate
granted -
US 8367734
Stable epinephrine suspension formulation with high inhalation delivery efficiency
granted -
US 7468394
Sterile pharmaceutical composition and process for a solution of propofol emulsion having microbial growth retardation
granted -
US 6399087
Propofol formulation with enhanced microbial inhibition
expired
Frequently asked questions
How many patents does Amphastar France Pharmaceuticals have?
15 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Amphastar France Pharmaceuticals patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.